ADCT · ADC Therapeutics SA · Documents
$1.52
+0.08 (+5.56%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$190.22M
Shares
127.67M
Volume · Oct 20
1.06M
Avg daily vol (3M)
1.52M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2021-08-03 | 2021-06-30 | |
| 6-K | — | 2021-07-28 | — | |
| 6-K | — | 2021-06-22 | — | |
| 6-K | — | 2021-06-21 | — | |
| 6-K | — | 2021-06-11 | — | |
| 6-K | — | 2021-06-09 | — | |
| F-3ASR | — | 2021-06-04 | — | |
| 6-K | — | 2021-06-04 | — | |
| 6-K | — | 2021-06-01 | — | |
| F-3ASR | — | 2021-06-01 | — | |
| 6-K | — | 2021-05-27 | — | |
| 6-K | — | 2021-05-26 | — | |
| 6-K | — | 2021-05-20 | 2021-05-19 | |
| 6-K | — | 2021-05-17 | — | |
| 6-K | — | 2021-05-12 | 2021-05-05 | |
| 6-K | — | 2021-05-06 | 2021-05-05 | |
| 6-K | — | 2021-05-06 | 2021-03-31 | |
| 6-K | — | 2021-05-04 | — | |
| 6-K | — | 2021-04-29 | — | |
| 6-K | — | 2021-04-23 | — | |
| 6-K | — | 2021-04-14 | — | |
| 6-K | — | 2021-04-06 | — | |
| 6-K | — | 2021-03-18 | 2020-12-31 | |
| 20-F | — | 2021-03-18 | 2020-12-31 | |
| 6-K | — | 2021-03-18 | — | |
| 6-K | — | 2021-03-11 | — | |
| 6-K | — | 2021-02-25 | — | |
| 6-K | — | 2021-02-05 | — | |
| 6-K | — | 2021-02-04 | — | |
| 6-K | — | 2021-01-07 | — | |
| 6-K | — | 2021-01-04 | — | |
| 6-K | — | 2020-12-14 | — | |
| 6-K | — | 2020-12-07 | — | |
| 6-K | — | 2020-11-30 | — | |
| 6-K | — | 2020-11-20 | — | |
| 6-K | — | 2020-11-12 | — | |
| 6-K | — | 2020-11-10 | — | |
| 6-K | — | 2020-11-05 | — | |
| 6-K | — | 2020-11-04 | — | |
| 6-K | — | 2020-11-03 | — | |
| 6-K | — | 2020-10-30 | — | |
| 6-K | — | 2020-10-09 | — | |
| 6-K | — | 2020-09-24 | 2020-09-23 | |
| F-1 | — | 2020-09-21 | — | |
| 6-K | — | 2020-09-21 | — | |
| 6-K | — | 2020-09-21 | — | |
| 6-K | — | 2020-09-17 | — | |
| 6-K | — | 2020-09-10 | — | |
| 6-K | — | 2020-09-08 | 2020-09-04 | |
| 6-K | — | 2020-08-18 | — |
Showing 151–200 of 212 filings
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
10 filings
10 filers
Visit website
Investor relations